Jared Polis signed legislation this summer to expand access to weight loss treatments, including allowing employers to opt into covering GLP-1s
Studies are also underway to assess the efficacy of GLP1s for: Addiction: Semaglutide and Tirzepatide reduce alcohol consumption in individuals with obesity (Scientific Reports, Nature), Semaglutide for Alcohol Use Disorder (Phase II clinical trial by UNC) Alzheimer's: The mechanism and efficacy of GLP-1 receptor agonists in the treatment of Alzheimers disease (Frontiers in Endocrinology) Mental Health & Suicidal Ideation: Most GLP-1 Medications Correlated with a Lower Likelihood of Anxiety and Depression Diagnoses (Epic Research) Alcohol-related liver disease ( Novo Nordisk clinical trial ) Osteoarthritis ( STEP 9 ) Metabolic dysfunction-associated steatohepatitis (MASH): Tirzepatide for Metabolic DysfunctionAssociated Steatohepatitis with Liver Fibrosis This is just the beginning
With continued use, you'll see how firmness improves and expression lines soften
Drinking on semaglutide and drinking on tirzepatide is possible but comes with metabolic consequences that directly affect weight loss progress
They promote vasodilation or widening of the blood vessels to increase blood flow to parts of the body that require more nutrients and oxygen
First, side effects are clearly dose-dependent, increasing as the dose goes up